Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 6/18/2025

Perioperative Management of Medications

Medication Continuation

  • The Society for Perioperative Assessment and Quality Improvement (SPAQI) consensus statement recommends continuing Adderall through the perioperative period, including the morning of surgery, as there is no need to stop it before surgery based on current evidence 1
  • Adderall can be safely continued through surgery, and anesthesiologists should be informed about its use due to potential risks of interaction with butorphanol or nalbuphine, which may increase the risk of serotonin syndrome 1
  • Buspar (buspirone) can also be continued through the perioperative period, including the morning of surgery, as no specific recommendation to discontinue it appears in the SPAQI consensus statement 1

Medication Discontinuation

  • Ergotamine should be held at least 2 days prior to operation 1
  • Butalbital should be held but requires careful management if used long-term 1
  • Naltrexone should be held 3-4 days before surgery (oral) or 24-30 days (intramuscular) 1

General Recommendations

  • Inform the anesthesiologist about all medications the patient is taking, as abrupt discontinuation of long-term medications could potentially lead to withdrawal symptoms or exacerbation of the underlying condition 1
  • Be aware of potential serotonergic effects when combining buspirone with other perioperative medications that affect serotonergic systems 1